The effect of hypermagnesemia treatment on cerebrospinal fluid magnesium level in patients with aneurysmal subarachnoid hemorrhage

Magnesium Research

Volumn 22, Issue 2, 2009, Pages 60-65

  Wong, George K C ^a,b   Lam, Christopher W K ^a   Chan, Mathew T V ^a   Gin, Tony ^a   Poon, Wai S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebrospinal fluid; Intracranial aneurysm; Magnesium; Subarachnoid hemorrhage

Indexed keywords

MAGNESIUM; MAGNESIUM SULFATE; NEUROPROTECTIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE; TIME; TREATMENT OUTCOME; URINE;

ADULT; AGED; CEREBROSPINAL FLUID; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNESIUM; MAGNESIUM SULFATE; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650818943     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2009.0167     Document Type: Article

References (21)

1. Perales AJ, Torregrosa G, Salom JB. In vivo and in vitro effects of magnesium sulfate in the cerebrovascu- lar bed of the goat. Am J Obstet Gynecol 1991; 165: 1534-8.
2. 2+ in isolated human cerebral arteries. Eur J Pharmacol 1992; 229: 83-9.
3. Ram Z, Sadeh M, Shacked I. Magnesium sulfate reverses experimental delayed vasospasm after subarachnoid hemorrhage in rats. Stroke 1991; 22: 922-7.
4. Zhang L, Rzigalinski BA, Ellis EF, Satin LS. Reduction of voltage dependent Mg2+ blockade of NMDA current in mechanically injured neurons. Science 1996; 274: 1921-3.
5. Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium sulfate infusions in cerebral infarct. Magnes Res 1998; 11: 43-56.
6. Nowak L, Bregestovski P, Ascher P. M agnesium gates glutamate-activated channels in mouse central neurons Nature 1984; 307: 462-5.
7. Lin JY, Chung SY, Lin MC. Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique. Life Sci 2002; 71: 803-11.
8. van den Bergh WM, Dijkhuizen RM, Rinkel GJ. Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 2004; 17: 301-13.
9. Meloni BP, Zhu H, Knuckey NW. Is magnesium neuro- protective following global and focal ischaemia? Are- view of published studies. Magnes Res 2006; 19: 123-37.
10. Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery 2000; 47: 602-7.
11. Chia RY, Hughes RS, Morgan MK. Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. JClin Neurosci 2002; 9: 279-81.
12. van den Bergh WM. on behalf of the MASH study group. Magnesium sulfate in aneurysmal subarachnoid hemorrhage. Stroke 2005; 36: 1011-5.
13. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mly- narek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD. Magnesium sulfate therapy after aneurysmal sub- arachnoid hemorrhage. JNeurosurg 2002; 96: 510-4.
14. Wong GK, Chan MT, Boet R, Poon WS, Gin T. Intravenous magnesium sulfate after aneurysmal subarach- noid hemorrhage: a prospective randomized pilot study. J Neurosurg Anesthesiol 2006; 18: 142-8.
15. Wong GK, Chan MT, Poon WS, Boet R, Gin T. Magnesium within 48 hours of an aneurysmal SAH: neuropa- nacea. Neurological Res 2006; 28: 431-5.
16. McKee JA, Brewer RP, Macy GE, Phillips-Bute B, Cam- pell KA, Borel CO, Reynolds JD, Warner DS. Analysis of the peripheral brain bioavailability of peripheral administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia. Crit Care Med 2005; 33: 661-6.
17. Lampl Y, Geva D, Gilad R, Eshel Y, Ronen L, Sarova- Pinhas I. Cerebrospinal fluid magnesium level as a prognostic factor in ischemic stroke. J Neurol 1998; 245: 584-8.
18. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with pre-eclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 1987; 157: 1435-8.
19. Fuchs-Buder T, Tramer MR, Tassonvi E. Cerebrospinal fluid passage of intravenous magnesium sulfate in neu- rosurgical patients. JNeurosurg Anesthesiol 1997; 9: 324-8.
20. Investigators IMAGES. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke Trial): Randomized controlled trial. Lancet 2004; 363: 439-49.
21. Cruikshank DP, Pitkin RM, Donnelly E, Reynolds WA. Urinary magnesium, calcium, and phosphate excretion during magnesium sulfate infusion. Obstet Gynecol 1981; 58: 430-4.